← Back to Clinical Trials
Recruiting NCT05437198

NCT05437198 Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05437198
Status Recruiting
Phase
Sponsor Centre Hospitalier Intercommunal Creteil
Condition Chronic Obstructive Pulmonary Disease
Study Type OBSERVATIONAL
Enrollment 240 participants
Start Date 2024-03-26
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL
Interventions
collection of human exhalation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 240 participants in total. It began in 2024-03-26 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

COPD and non-COPD patients will be included in the study after collection of their non-objection. The exhalation will be collected to study the microbiological diversity of human exhalations. a second collection for the year +1 will be made, at the same time (between October and March).

Eligibility Criteria

Inclusion Criteria: For COPD: * Patients with chronic obstructive pulmonary disease * Age: over 18 For non-COPD * Absence of chronic obstructive pulmonary disease * Age: between 18 and 30 years old and between 45 and 70 years old Exclusion Criteria: * Taking certain medications in the month preceding the sample (antibiotics, systemic corticosteroids, immunosuppressants) * Person under guardianship or curatorship * Pregnant or breastfeeding women * Person unable to express his/her opposition, person deprived of liberty * Existence of a chronic infectious pulmonary pathology such as (dilation of the bronchi, cystic fibrosis)

Contact & Investigator

Central Contact

Jean-Claude PAIRON, PhD

✉ jc.pairon@chicreteil.fr

📞 01 45 02 20 93

Principal Investigator

Jean Claude PAIRON, PhD

PRINCIPAL INVESTIGATOR

CHI créteil

Frequently Asked Questions

Who can join the NCT05437198 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05437198 currently recruiting?

Yes, NCT05437198 is actively recruiting participants. Contact the research team at jc.pairon@chicreteil.fr for enrollment information.

Where is the NCT05437198 trial being conducted?

This trial is being conducted at Créteil, France.

Who is sponsoring the NCT05437198 clinical trial?

NCT05437198 is sponsored by Centre Hospitalier Intercommunal Creteil. The principal investigator is Jean Claude PAIRON, PhD at CHI créteil. The trial plans to enroll 240 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology